Few people know of the current state of anabolic androgenic steroids
(AAS); it may be rarer still to find someone with knowledge of the
history of anabolic steroids. Sadly, the best texts on the subject
directly from the pioneers are difficult to locate as they have been out
of print for decades, such as Charles Kochakian’s Anabolic Actions of Steroids and Remembrances.1 One exception is the recent text Testosterone Dreams: Rejuvenation, Aphrodisia, Doping by John Hoberman, which is excellent.2
However, policymakers and their clinical gatekeepers (physicians) do
not generally take time to read much outside of their specialties, do
not refer to popular media, and rely heavily on reviews and research in
academic texts.
Considering the conflict that arises between recreational anabolic
steroid users and the regulatory agents of medical professionals and
legislative policymakers, it should be of interest to learn the history
of the development of AAS as it is presented to health care providers
and elected officials. A recent review was published in Pediatric Clinics of North America.3 Each issue of Pediatric Clinics of North America
is devoted to a single topic, magnifying the impact of each article.
This review is interesting in that it focuses on the relatively
primitive techniques used to identify a ‘male factor’ and then isolate
the responsible molecule.
The review also touches on the pioneering efforts (some misguided,
others seemingly barbaric) in applying the male factor and later
testosterone to provide restorative therapy to men. It should be of no
surprise to anyone that the desired endpoint for many patients was to
restore or enhance male sexual prowess. Despite any measurable advance
in civilized endeavors over the last 6,000 years, enhancing male sexual
prowess remains a driving influence, as demonstrated by the sales of
Viagra and related drugs, as well as the comments made on the effect of
certain other drugs, such as Melanotan II.4,5
Recreational and competitive sports did not hold the position in
society that they do now, and the display of one’s body was considered
vulgar and vain until the relatively puritanical era of the early- to
mid-20th century passed. Thus, there was relatively little mention of
sports performance enhancement until the 1950s. Of course, physique
development and performance enhancement are now considered to be the
dominant purposes for the use of testosterone and related anabolic
steroids (AAS). However, when questioned in a large survey, most users
admitted that attracting potential sexual partners remains the primary
reason for steroid use (by improving one’s physique or social status
through athletic performance).6 The more things change, the more they stay the same.
Myriad Effects of Androgens
The review, authored by Drs. Dotson and Brown, of Columbus Children’s
Hospital and The Ohio State University respectively, begins by
discussing [some of] the myriad effects of endogenous (natural) androgens— anabolic (tissue-building) and androgenic (masculinizing).3
It is interesting that they label vocal cord-thickening and laryngeal
(voice box) enlargement as anabolic, when many consider those to be
masculinizing effects.
The history of the pursuit of AAS is acknowledged to have begun over
6,000 years ago as farmers and herders castrated animals to make them
easier to domesticate.3 Many married men might jokingly
identify with this in a figurative sense, as demonstrated in the comedy
routine of the late Sam Kinison: “You’re married now, I guess you won’t
be needing this.”
The earliest surviving recorded curatives for impotence or libido
problems date back to the Yellow Emperor’s (Huang Ti) Dynasty of China
from approximately 2600 B.C. Later, but still ancient cures from the
eighth century B.C. are described in writings from India and the Middle
East, the ‘cradle of civilization.’ Moving along the timeline, it is
revealed that the Egyptians (1600 B.C.), India (eighth century B.C.) and
Romans would prepare elixirs and potions, consuming testicles and
animal penises to obtain mystical ‘powers.’7 Those with a
liberal arts education might immediately wonder what psychoanalyst
Sigmund Freud would think of such behavior. Interestingly, Freud appears
later in the history of AAS.
It was the Greeks who introduced the idea of using the sexual organs
of animals or phallus-shaped plants for performance enhancement in
sports, at least in Western cultures. Of course, prior to the era of
Greek culture, sports took place in gladiatorial arenas where
enhancement usually involved heavier armor or more lethal weapons. It is
amazing how the Greeks and Romans are revered for their architectural
and philosophical advances, but no mention is ever made of their forage
into performance enhancement.
The review leaps forward to the late 1700s, a revolutionary time in
more ways than one. Scottish surgeon John Hunter was the Royal Surgeon
to King George III and a distinguished scholar. He was a strong advocate
of observation and experimentation. Some of his rumored behavior is
indisputably odd by today’s standards— self-inoculating himself with
venereal disease to study the progress of the disease, and displaying
the skeleton of a man who suffered from gigantism against his deathbed
wishes, after acquiring the remains through bribery.8
Hunter is believed by many to be the Scottish equivalent to da Vinci,
and one of the United Kingdom’s esteemed professional societies bears
his name. Hunter performed the first documented testicular transplant
(from a rooster to a hen), resulting in androgenic features in the hen.9
Several decades later, German physiologist Arnold Berthold proved that a
substance in the bloodstream produced the male features in roosters,
but his findings went largely unnoticed.3,9,10
Pissing Contests and Testicular Transplants
One of the preeminent names in endocrinology is Charles-Édouard
Brown-Séquard, who lived from 1817 to 1894. Many tales of his work
during his tenure as a Harvard professor abound, including stories of
experimenting upon himself with self-injections of testicular extracts
from guinea pigs and dogs. Brown-Séquard published a famous report of
his [subjective] increased strength, mental abilities, and appetite, relief from constipation and an increased arc in his urine stream.11
On the face of things, it appears that Brown-Séquard was interested in
combating aging-related symptoms of androgen deficiency. A close friend
whose career is in academics suggests that he might have been involved
in performance enhancement, since half of a professor’s time is spent in
departmental pissing contests. This comment was made in jest, but it
reflects the underlying tension and competition that pervades all levels
of modern society— even the hallowed halls of academia.
According to the review, the first people to propose injecting
athletes with hormonal substances were Austrian physiologist Oskar Zoth
and his physician partner, Fritz Pregl in 1896.3 They
self-injected testosterone extracts from bulls and plotted the strength
of their middle fingers on ‘fatigue curves.’ Pregl went on to win the
Nobel Prize in chemistry in 1923 for unrelated work. Why they chose to
use the middle finger is a matter of speculation, though again, Sigmund
Freud might offer some insight.
The late 1800s and early 1900s were years of frenetic study in the
signaling of the body. Two prominent English physiologists, Bayliss and
Starling, coined the term ‘hormone’ from the Greek for ‘to impulse or
arouse.’12
In 1911, the first suggestion of a dose-response curve was published
when André Pézard observed that a rooster developed a more prominent
comb with greater doses of extract.3,10 At this point,
physicians began to use rudimentary operations that by today’s standards
are bizarre and replete with risks of infection and tissue rejection.
The ‘Steinach operation’— basically a vasectomy— was provided to
‘middle-aged and listless’ men. The claimed benefits of the Steinbach
operation included hair regrowth, better erections, reduced complaints
of premature ejaculation, and improved libido. Critics believed
Steinbach’s claims were due to placebo effect, but his list of patients
included prominent intellectuals, including Sigmund Freud and William
Butler Yeats.3 Again, my esoteric and overeducated friend
commented that Steinbach probably whispered, “Your mother loves you”
into Freud’s ear during the procedure to ensure his sexual arousal.
The more alarming trend that was being practiced during this time was
testicular transplantation from ‘donors’ into patients. Many of the
donors were recently-executed prisoners and the early patients were
often fellow prisoners.3 Of course, that sort of treatment is
no longer tolerated in the U.S. penal system. One affluent surgeon
developed a technique wherein he would slice the donor testicle(s)
lengthwise prior to implanting the tissue slices between muscle layers
in the abdomen or pelvis. His patients apparently included the
well-connected and wealthy, as the case of one patient was reported in The New York Times— Harry F. McCormick, husband of Edith Rockefeller.3
Within years, the supply of testes donors could not meet demand, and
certain entrepreneurial surgeons substituted the testicles of rams,
boars, chimpanzees, and other mammals. Animal rights activists
campaigned against this practice and editorial cartoonists (the early
predecessors to Jay Leno) were quick to publish their parodies.
Testes Extracts to Boost Performance?
For modern-day AAS users, the history of AAS begins in the late 1920s
when scientists were scrambling to discover the chemical containing the
androgenic properties of these testes extracts responsible for
providing the improvements in vitality and sexuality. The first related
success occurred in 1929 when German chemist Adolf Butenandt isolated
the female sex hormone estrone from the urine of pregnant females. Just
two years later, Butenandt isolated androsterone.3,13 As
overjoyed as current AAS users may be at hearing of the discovery,
Butenandt was likely more ecstatic, as the 15 mg of androsterone was
filtered from 15,000 liters of urine from local policemen.3,9
Androsterone is a metabolite of testosterone, a waste product excreted
after testosterone has been enzymatically degraded, removing most of the
androgenic and anabolic properties.
The race commenced among pharmaceutical companies, recognizing the
unmet demand from men for a treatment for decreased vitality, as well as
depressed libido and sexual function. Within months of each other,
several chemists published papers on various methods of synthesizing
testosterone from chemical precursors, such as cholesterol. Butenandt,
one of the primary chemists, received the Nobel Prize in chemistry for
his work with sex hormones in 1939.13 As material became
available, clinical experiments with men suffering from hypogonadism
were undertaken, focusing on impotence and sexual desire. It is worthy
to note that topical preparations were also formulated to promote sexual
desire in women by 1939.3 Remember, this was as the United
States was exiting the Great Depression, the only financial crisis worse
than today’s economic calamity (so far).
It was the discovery by Charles Kochakian that the male sex hormone has properties that are anabolic as well as androgenic.1,3,14
The anabolic function of androgenic steroids captured as much attention
as the sexual functions. In 1945, Paul de Kruif published a book titled
The Male Hormone, which reported the increased libido and enhanced athletic performance provided by testosterone and related drugs.15 The world was just recovering from World War II.
Sports and Bodybuilding
From the late 1940s to today, the history of AAS diverts into the
realm of sports and bodybuilding. Many of the clinical uses were
replaced by more specific treatments; reports of masculinizing side
effects in women and liver tumors with chronic use of oral agents caused
the class of drugs to fall into disfavor. By the late 1960s, it was
suspected that much of the profit from AAS came from black-market
distribution. Nonetheless, clinical experimentation on aging men
suffering from signs of hypogonadism continued. Paul Niehans, author of
the 1960 text Introduction to Cellular Therapy, provided testicle cell injections to prestigious patients such as Pope Pius XII and Aristotle Onassis.3,16
Despite the unmet demand and growing knowledge base, pharmaceutical
companies discontinued AAS production as regulatory and social pressures
were applied. This reduction in resource allocation to AAS research
coincided with the first Anabolic Steroid Control Act, making the
distribution, use and possession of AAS without a physician’s
prescription a felony. While the pharmaceutical companies have developed
a number of novel (patentable) delivery mechanisms for testosterone,
(patches, gels, non-alkylated oral Andriol, long-acting Nebido, and
intranasal), the main crux in development has been toward non-steroidal
selective androgen receptor modulators (SARMs).17 This leaves the United States demand for testosterone and other AAS unmet by legitimate, licensed and regulated manufacturers.
This void was quickly filled by the black market. Initially, finished
products from Mexican, Pacific Rim, or European pharmaceutical
companies were shipped or smuggled into the United States.18
As the delivery of these compounds became more uncertain due to actions
of the Drug Enforcement Administration, U.S. Customs, U.S. Postal
Inspectors, Homeland Security, etc., underground labs began meeting
demand by purchasing AAS precursors from China, Mexico, India and other
countries.19 These compounds were not monitored as closely
and could be imported more easily, particularly if they were mislabeled
from the point of origin. Unfortunately, the purity and potency of the
precursors and finished products were often well below pharmaceutical
standards. Cases of intentional adulteration or frank fraud have been
reported, at times resulting in injury to the end user.
Dotson and Brown ended the review discussing the uncertain role
testosterone and AAS have in clinical medicine, reported side effects,
and the incidence and impact of adolescent drug abuse.3
Though these are all important topics to consider and address, their
discussion diverts the reader’s attention away from the original intent
of the article, the history of AAS.
The review was interesting and valuable, but it does no service to
the readers of this article merely to reiterate the points presented.
Instead, it is interesting to look at some of the highlights and
consider them in light of the current position of AAS in the clinical,
social and economic times.
Ethics, Risks and Gym Rats
AAS are considered by the public, policymakers, and professionals
solely as illicit performance-enhancing drugs used by athletes and
adolescents without regard of ethics or risks. Legislators, the media,
and prosecutors have labeled anyone involved or interested in the field
of AAS as unscrupulous pharmacies, rogue physicians, criminals, and
scorned athletes. Yet, the history of AAS identification and development
includes some of the most notable names in the fields of physiology,
chemistry, medicine, surgery and endocrinology. The Nobel Prize has been
granted to some who have experimented with and studied the potential of
using AAS or related compounds to restore or enhance health and
performance. Those who have sought the restorative powers of the humoral
or glandular male factor, primarily for decreased libido, impotency,
and signs of aging-related decline in androgen status, include notable
figures in religion, science, psychology and industry. The demand for a
better quality of life prevailed through some of the greatest global and
national challenges in history, including the Great Depression and
World War II.
It is not only the athletes and ‘gym rats’ buying AAS through the
black market for sports titles and larger muscles who are placed in
harm’s way by the antithetical turn from the 6,000 year-pursuit of the
male factor. It is every man seeking to delay or reverse the
deterioration in vitality, independence and esteem that occur almost
inevitably with aging. It is every healthy man seeking to improve his
social status or sexual attractiveness by improving his appearance and
performance, both physical and sexual. These goals may seem vain, but
they are an innate driving force, embedded within the nature of mankind,
as evidenced by the presence of such demand since recorded time.
The rush to innovate drives America’s competitive place in the
international market. Yet, it is the country that is trying to quash,
and thus create a black market for, research and development in
life-enhancing therapies. The history of AAS should establish that the
field has been part of mankind’s recorded history, been nurtured by and
advanced through the efforts of some of the greatest minds in medicine,
science, religion and industry. Perhaps a better understanding of the
history of AAS could alleviate many of the concerns of policymakers and
professionals, redirecting development, supporting research and relaxing
indications for clinical use.
References:1. Kochakian C. Anabolic Actions of Steroids and Remembrances. University of Alabama Press, Birmingham, AL;1984. ISBN-13: 9789994291205.
2. Hoberman J. Testosterone Dreams: Rejuvenation, Aphrodisia, Doping. University of California Press, Berkeley, CA;2005. ISBN-13: 9780520221512.
3. Dotson JL, Brown RT. The history of the development of anabolic-androgenic steroids. Pediatr Clin North Am, 2007 Aug;54(4):761-9.
4. Lexchin J. Bigger and better: how Pfizer redefined erectile dysfunction. PLoS Med, 2006 Apr;3(4):e132.
5. Evans-Brown M, Dawson RT, et al. Use of melanotan I and II in the general population. BMJ, 2009 Feb 17;338:b566.
6. Cohen J, Collins R, et al. A league of their own: demographics, motivations and patterns of use of 1,955 male adult non-medical anabolic steroid users in the United States. J Int Soc Sports Nutr, 2007 Oct 11;4:12.
7. Shah J. Erectile dysfunction through the ages. BJU Int, 2002 Sep;90(4):433-41.
8. Kobler J. The Reluctant Surgeon. The Akadine Press, Pleasantville, NY;1999. ISBN-13: 978-1888173963.
9. Freeman ER, Bloom DA, et al. A brief history of testosterone. J Urol, 2001;165:371-3.
10. Medvei VC. The History of Clinical Endocrinology. Parthenon Publishing Group, Pearl River NY;1993. ISBN-10: 1850704279.
11. Brown-Séquard CE: Note on the effects produced on man by subcutaneous injections of a liquid obtained from the testicles of animals. Lancet, 2:105-107:1889.
12. Henderson J. Ernest Starling and 'Hormones': an historical commentary. J Endocrinol, 2005 Jan;184(1):5-10.
13. Karlson P. Adolf Butenandt (1903-1995). Nature, 1995 Feb 23;373(6516):660.
14. Hoberman JM, Yesalis CE. The history of synthetic testosterone. Sci Am, 1995 Feb;272(2):76-81.
15. de Kruif P. The Male Hormone. Permabooks, New York;1948. ASIN: B000KD7ECO.
16. Lambert G. Conquest of Age. The extraordinary story of Dr. Paul Niehans. Rinehart & Company Inc., New York; Clarke, Irwin & Company Limited,Toronto;1959. ASIN: B001UC6GDM.
17. Gao W, Dalton JT. Expanding the therapeutic use of androgens via selective androgen receptor modulators (SARMs). Drug Discov Today, 2007 Mar;12(5-6):241-8.
18. Ryan J. DEA Announces Charges in Largest Ever Steroid Probe. ABC News 2005 December 15. Available at: http://abcnews.go.com/US/LegalCenter/story?id=1411333, accessed April 9, 2009.
19. Schmidt MS. U.S. Arrests 124 in Raids on Global Steroid Ring. The New York Times, 2007 September 24. Available at: http://www.nytimes.com/2007/09/24/sports/24cnd-steroid.html?ref=sports, accessed April 9, 2009.
No comments:
Post a Comment